This project is based on the preliminary findings that an oxothiolane class of nucleosides (+/-)-BCH-189 and its analogues have shown potent antiviral activity against human hepatitis B virus. We have synthesized an enantiomerically pure (-)-L and (+)-D-BCH-189 from L-gulose and D- mannose, respectively, and discovered that (-)-L-BCH-189 is the most potent isomer against human hepatitis B virus (HBV). Furthermore, the (-)-L-BCH-189 was found to be significantly less toxic than the (+)-D- BCH-189. The superior anti-HBV activity of (-)-L-BCH-189 may be explained based on the fact that (+)-D-BCH-189 is susceptible to deamination by deoxycytidine deaminase while (-)-L-BCH-189 is completely resistant to the deaminase under the similar conditions. Thus, this application proposes the extension of this exciting preliminary findings to synthesize various pyrimidine and purine analogues of oxathiolane L- nucleosides for exhaustive structure-activity relationship studies against HBV. Additionally, assymmetric synthesis of dioxolane L- nucleosides as well as their C-nucleoside analogues will be synthesized. In vitro antiviral activity of the synthesized compounds will be evaluated in the 2.2.15 cells derived from HepG2 cells that were transfected with a plasmid containing HBV. Additionally, biochemical, molecular biological and toxicological (in vitro) studies will be performed with the (-)-L-BCH-189 as well as other promising drug candidates. Furthermore, in collaboration with the National Institute of Allergy and Infectious Diseases, a certain promising drug candidate will be studied in vivo woodchuck hepatitis B model to assess the anti- HBV as well as the toxicity. The long term goal of this application is to discover and develop clinically effective and safe antiviral agents for HBV which is currently lacking despite enormous problems in the world.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Georgia
Schools of Pharmacy
United States
Zip Code
Gumina, G; Song, G Y; Chu, C K (2001) Advances in antiviral agents for hepatitis B virus. Antivir Chem Chemother 12 Suppl 1:93-117
Choi, Y; Li, L; Grill, S et al. (2000) Structure-activity relationships of (E)-5-(2-bromovinyl)uracil and related pyrimidine nucleosides as antiviral agents for herpes viruses. J Med Chem 43:2538-46
Hong, J H; Gao, M Y; Choi, Y et al. (2000) Synthesis of novel 3'-C-methyl-apionucleosides: an asymmetric construction of a quaternary carbon by Claisen rearrangement. Carbohydr Res 328:37-48
Chun, B K; Olgen, S; Hong, J H et al. (2000) Enantiomeric syntheses of conformationally restricted D- and L-2', 3'-dideoxy-2',3'-endo-methylene nucleosides from carbohydrate chiral templates. J Org Chem 65:685-93
Kira, T; Grill, S P; Dutschman, G E et al. (2000) Anti-Epstein-Barr virus (EBV) activity of beta-L-5-iododioxolane uracil is dependent on EBV thymidine kinase. Antimicrob Agents Chemother 44:3278-84
Li, L; Dutschman, G E; Gullen, E A et al. (2000) Metabolism and mode of inhibition of varicella-zoster virus by L-beta-5-bromovinyl-(2-hydroxymethyl)-(1,3-dioxolanyl)uracil is dependent on viral thymidine kinase. Mol Pharmacol 58:1109-14
Pierra, C; Olgen, S; Cavalcanti, S C et al. (2000) Synthesis and antiviral activities of enantiomeric 1-[2-(hydroxymethyl) cyclopropyl] methyl nucleosides. Nucleosides Nucleotides Nucleic Acids 19:253-68
Chun, B K; Schinazi, R F; Cheng, Y C et al. (2000) Synthesis of 2',3'-dideoxy-3'-fluoro-L-ribonucleosides as potential antiviral agents from D-sorbitol. Carbohydr Res 328:49-59
Chu, C K; Ma, L; Olgen, S et al. (2000) Synthesis and antiviral activity of oxaselenolane nucleosides. J Med Chem 43:3906-12
Fu, L; Cheng, Y C (2000) Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus. Antimicrob Agents Chemother 44:3402-7

Showing the most recent 10 out of 43 publications